👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Silk Road Medical Inc (SILK)

NASDAQ
Currency in USD
Disclaimer
27.49
0.00(0.00%)
Real-time Data

SILK Income Statement

Advanced Income Statement
Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa138.64177.13
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+36.62%+27.77%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa37.8850.05
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa100.76127.09
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+32.53%+26.12%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa72.68%71.75%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa152.77186.36
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-52-59.27
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-9.56%-13.97%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-37.51%-33.46%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-2.573.09
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-10.82%+220.03%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-5.1-6.87
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa2.539.96
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa0.020.65
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-54.56-55.54
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-0.18-0.16
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-0.25-
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-54.98-55.7
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-10.42%-1.31%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-39.66%-31.45%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa0.030.04
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-55.01-55.74
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa--
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-55.01-55.74
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-10.44%-1.33%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-39.68%-31.47%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa--
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-55.01-55.74
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-1.54-1.44
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-6.92%+6.58%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-1.54-1.44
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-6.92%+6.58%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa35.7838.8
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa35.7838.8
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa--
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa--
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-49.88-56.58
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-7.41%-13.43%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-35.98%-31.94%
EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa-52-59.27
* In Millions of USD (except for per share items)